Enclosed is the weblink to register for a joint webinar on Azido impurities being conducted by Lhasa , DRL ANVISA and Sindusfarma
@DAB Thanks for sharing the link to the event.
Date: 8th December 2021
Time: 9am BRT | 5:30pm IST | 1pm CET
#1 Azido and nitrosamine impurities: Formation, similarities, differences, and its carcinogenicity.
#2 Work flow and risk assessment to tackle these impurities
#3 ANVISA Positioning and updates on Azido impurities
Fernanda Waechter - Lhasa @fernandaw
Raphael Sanchez Pereira - GQMED/GGMED
Rakeshwar Bandichhor - VP and Head of Chemistry, API-PR&D, Dr. Reddy’s
We have few discussions on the topics throughout the community:
Here you have the link to the EDQM method
Hello Naiffer, I am new to this community and looking forward to productive discussions. We were just asked about the USP current thinking regarding a method for the Azido impurity in sartans using LC-MS. Any insights you can share? Thank you!